This is the preview version of the Wisconsin State Legislature site.
Please see for the production version.
  Date of enactment: November 3, 2017
2017 Assembly Bill 335   Date of publication*: November 4, 2017
* Section 991.11, Wisconsin Statutes: Effective date of acts. “Every act and every portion of an act enacted by the legislature over the governor's partial veto which does not expressly prescribe the time when it takes effect shall take effect on the day after its date of publication."
An Act to renumber 961.14 (2) (a), (ae), (ai), (cd), (cg), (dg), (er), (eu), (ey), (fe), (nc), (ne), (qs), (rj), (tg) and (xm); to amend 961.01 (12g); and to create 961.14 (2) (nd) of the statutes; relating to: fentanyl analogs and providing a criminal penalty.
The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:
60,1 Section 1. 961.01 (12g) of the statutes is amended to read:
961.01 (12g) “Isomer" means an optical isomer, but in ss. 961.14 (2) (er) and (qs) and s. 961.16 (2) (b) 1. “isomer" includes any geometric isomer; in ss. 961.14 (2) (cg), (tg) and (xm) and s. 961.20 (4) (am) “isomer" includes any positional isomer; and in ss. 961.14 (2) (rj) (nd) and (4) and 961.18 (2m) “isomer" includes any positional or geometric isomer.
60,2 Section 2. 961.14 (2) (a), (ae), (ai), (cd), (cg), (dg), (er), (eu), (ey), (fe), (nc), (ne), (qs), (rj), (tg) and (xm) of the statutes are renumbered 961.14 (2) (nd) 1., 2., 3., 4., 5., 6., 7., 8., 9., 10d., 10t., 11., 14., 15., 17. and 19.
60,3 Section 3. 961.14 (2) (nd) of the statutes is created to read:
961.14 (2) (nd) Fentanyl analogs, including any compound, except compounds scheduled elsewhere in this chapter, structurally derived from fentanyl by replacement of the phenyl portion of the phenethyl group by any monocycle whether or not further substituted in or on the monocycle; by substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups; by substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups; by replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; by replacement of the N-propionyl group by another acyl group; or by any combination of these modifications. Substances specified under this paragraph include all of the following:
10. Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);
10p. 4-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]-butyramide);
12. Isobutyryl fentanyl (2-methyl-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-propanamide);
12w. Methoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);
12y. 3-methylbutyryl fentanyl (N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylbutyramide);
13. 4-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
16. Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);
18. Tetrahydrofuran fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
20. Valeryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide).